Tyme To Present Prostate Cancer Data From Its Ongoing Phase II Trial For SM-88 At Post author:Sam Post published:August 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Approval of Drug May Have Made This Bay Area Pharma a New M&A Target June 26, 2017 Google's Verily Employees Make Themselves at Home at Onyx's Former HQ March 23, 2017 FDA Clears Massachusetts Biotech Tesaro's Ovarian Cancer PARP Inhibitor March 27, 2017